Twist Bioscience Shares Upgraded to Outperform by Evercore ISI
Evercore cited the synthetic DNA maker's response to a recent report from a short seller that dragged down its shares toward the end of 2022.
Cowen Upgrades PerkinElmer Stock to Outperform
Analyst Max Masucci said the firm is expected to generate at least $3.21 billion in COVID-19-related revenues, while he lowered the stock price target to $164 per share.
Illumina Upgraded to Outperform by SVB Securities
The stock upgrade comes after Illumina launched a new instrument line and chemistry last week and held an investor showcase on Monday.
Illumina Upgraded to Outperform by Evercore ISI
The stock upgrade comes right before an event where Illumina has said it will provide information on a new sequencing-by-synthesis chemistry.
Cowen Initiates Coverage of Ginkgo Bioworks With Outperform Rating
Ginkgo Bioworks went public in September through a SPAC merger, raising $1.63 billion in proceeds. Cowen joins BTIG in covering shares of the firm.